You are here
What is exempt human subjects research?
"Exempt" human subjects research is a sub-set of research involving human subjects that does not require comprehensive IRB review and approval because the only research activity involving the human subjects falls into one or more specific exemption categories as defined by the Common Rule.
- Exempt projects are not subject to continuing review
- Amendments are required only if changes to the project could alter the exempt determination
- An exempt determination does not lessen the investigator's ethical obligations, including the completion of human subjects protections training (PEERRS or equivalent)
06/18/2018: HHS has delayed the "2018 Common Rule," including implementation of the new exemption categories and review paths, until January 21, 2019.
Proposed for implementation on January 21, 2019, the current federally-defined exemption categories for human subjects research and the U-M exemption review process will change, with:
- Modification to most existing categories
- Expansion in scope to several existing categories
- Addition of new categories
- New exempt determination processes applicable in specific circumstances:
These changes reflect the recent trends in research oversight to reduce administrative burden on investigators and IRBs for minimal-risk research.
If you have questions regarding the applicability of an exemption category to your proposed research, contact your U-M IRB for assistance prior to completing the IRB application.
The following lists the high-level changes for each exemption category and identifies the potential exemption review paths at U-M based on criteria for that exemption category. Further details about each exemption are available in the Common Rule Change presentations from IRBMED and/or IRB-HSBS.
#1 - Educational exemption
What's New: A new ineligibility criterion will be added to this interaction/intervention exemption for research that involves possible "adverse effects" on student learning of the required education content and/or on the assessment of educators.
Review Path: The Self-determination* review path is permitted unless the research involves the use of:
- Student education records (FERPA regulated), which requires an IRB Determination
- Protected health information (PHI) (HIPAA regulated), which requires an IRB Determination with (often) a Privacy Board review.
#2 - Surveys, interviews, educational tests, and observation of public behavior
What's New: The scope will be expanded to include the collection of sensitive and identifiable data. However, the following is not allowed:
- The collection of biospecimens
- Linking to additional personally-identifiable data
- Research with children (except for educational tests or some public observation)
Review Path: The Self-determination* review path is permitted if the data collected is not sensitive or not identifiable; but Limited IRB Review is required if it is.
# 3 - Benign behavioral intervention (NEW)
A "benign intervention" is defined as one that is brief in duration, harmless, not physically invasive, painless, not embarrassing or offensive, and not likely to have a lasting adverse impact.
What's New: This new exemption permits data collection via an interaction (e.g., survey, interview, audio/visual recording) from adult subjects with prospective agreement. However, the following is not allowed:
- Research with children
- Deception, unless prior agreement obtained
- Physiological data collection methods (e.g., EEG; wearable devices, such as FitBitTM; blood pressure monitors)
- Linking to additional personally-identifiable data
Review Path: The Self-determination* review path is permitted unless the research involves:
- Undisclosed deception, which requires a Comprehensive IRB Review
- The collection of sensitive and identifiable data, which requires a Limited IRB Review
This exemption adopts, but then modifies U-M Exemption 2a, which will be retired in July. The current federal exemption #3 will be eliminated.
What's New: The scope of this exemption will be expanded to allow:
- Prospective data review
- Maintenance of identifiers, if all study data is protected health information (PHI)
- Research that is conducted by, or on behalf of, a Federal department/agency or using government-generated or government-collected information obtained for non-research activities
#5 - Public benefit/service program research (federal demonstration projects)
What's New: A new eligibility criterion for this interaction/intervention exemption will be that the project must be published on a federal website.
Review Path: An IRB Determination is required with validation from the U-M HRPP Director.
Note: U-M will continue to apply exemption #5 to public benefit and service programs sponsored by the State of Michigan.
#6 - Taste/food quality evaluation & consumer acceptance
What's New: Unchanged
Review Path: An IRB Determination is required.
What's New: This new exemption allows for the storage of data and/or specimens in a repository, with identifiers maintained, that were collected under an approved IRB protocol with "Broad Consent" for future secondary use research.
U-M will not implement Exemption #7 at this time
#8 - Use of identifiable data/biospecimens obtained with "broad consent" (NEW)
What's New: This new exemption allows for secondary research use/analysis of identifiable data/biospecimens that were collected under an approved IRB protocol with "Broad Consent".
U-M will not implement Exemption #8 at this time
IRB Application Changes
As exemptions are possible for both research involving an interaction or intervention and secondary use research, U-M is taking this opportunity to streamline the IRB application (HUM) and leverage more of the eRRM system's "smartform logic" and routing functionality. Specifically:
- The Exempt application type will be retired and will no longer appear as an option in HUM section 1-1.1
- The Standard application type will be renamed "Human subjects research involving interaction or intervention" to reflect its use for all research involving the collection of new data or biospecimens from human subjects
- An "exemption screener" (i.e., a sub-set of HUM questions) will be added to the "interaction/intervention" application to:
- Identify whether a particular exemption category applies to the research activity
- Route the application along the applicable review path (i.e., one of the exemption paths or comprehensive IRB review)
Selection of an exemption category will display the Exemption Details page, which is used to qualify the project for exemption or, if not qualified, to route the application to the next question in the comprehensive IRB review path.
- The Secondary Use application type will be renamed "Secondary research uses of private information and/or biospecimens". This application type is designed to route all secondary use studies through the correct IRB review and determination path (i.e., not regulated, exempt, or comprehesive IRB approval) based on the answers to the questions; eliminating the need for study teams to self-identify the required level of review.
Note: all other application types (e.g., Not Regulated, Requesting Review by a Non-UM IRB, etc.) remain unchanged and will continue to be options in HUM section 1-1.1.
Self-determination means that the Principal Investigator is permitted to issue a system-generated exemption determination letter based on responses to key questions within qualifying human subjects exemption categories. The IRB does not review self-determined projects. Investigators may choose not to apply self-determination but, instead, choose to submit a study for an IRB determination of exemption. In eRRM, this process will be similar to the one currently available for some Not Regulated projects.
* If the research conducted by Michigan Medicine affiliates (and other units within the HIPAA covered entity) involves access to PHI data for the purposes of identifying potential subjects, then self-determination is NOT permitted.
U-M will implement a post-determination validation process for self-determinations to ensure that the exemption criteria are being applied in accordance with regulatory requirements and that the potential risk to human subjects remains minimal.
Limited IRB Review is a type of expedited review process required in the Common Rule. Its purpose is to ensure privacy/confidentiality protections are in place with exempt research that involves the collection or use of sensitive, identifiable data (exemptions 2, 3 and 8) and, for exemption 7, that "broad consent" was obtained and (if appropriate) documented according to an approved protocol. For exempt studies involving access to PHI (e.g., from medical records), the required Privacy Board review may be integrated with Limited IRB Review by the same assigned reviewer.
The new Termination Report function in eRRM will be made available for exempt studies to close the study upon completion of the research. For details see: Termination Report.
- Existing Exempt studies will not be converted to the new "interaction/intervention" application type. Future amendments will be permitted for administrative changes only (i.e., for personnel changes or to record new funding for the project). For changes to the research design you will be required to file a new application.
- Existing Secondary Use studies will be converted to the new "Secondary research uses of private information and/or biospecimens" application type. Amendments for either administrative changes or for research design changes are allowed, but will require review and re-answer to some existing questions due changes within the application.
- Existing Standard studies will have the new "exemption screener" page added. At the next amendment, this page will be required. For unambiguously non-exempt projects, this means one new question. Some existing studies approved via full board or expedited review may now qualify for exemption under the 2018 Common Rule. The new exempt status can be determined via an amendment.
New studies submitted for an exempt determination (including self-determination) after January 21, 2019 will utilize the new application types. The revised Common Rule will apply to these studies.
IRB applications submitted for exempt determination shortly before January 21, 2019 may not be reviewed by the IRB in time to qualify under the current human subjects protection regulations. The U-M IRBs encourage study teams to submit applications well before January 21, 2019 or to delay submission to take advantage of the new application types and revised regulations. Check the IRB Metrics for median submission-to-approval turnaround times for exemptions to plan accordingly. Exempt applications in process at the time of transition will be returned to the study team to be updated using the new application types.